Moreover, USP31 was highly expressed in 8 out of 27 larynx carcinomas (30%), and only in 2 out of 31 normal tissues, where its expression was restricted to the proliferative basal layer (data not shown). The gene discussed is USP31; the disease is laryngeal carcinoma.